Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3488 results

Sort By:

Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Caesarean Section

Study ID: NCT06797973
Start Date: 2025-06-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

1312

Intervention / Treatment

Intrathecal Morphine

Placebo (Sodium Chloride Injection, 0.9%)

Sponsor

Zealand University Hospital

Source: clinicaltrials.gov

Share:
Add to list

PROgram to Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder

Study ID: NCT06488573
Start Date: 2026-02
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

74

Intervention / Treatment

Nutritional intervention

Sponsor

University of Sao Paulo

Source: clinicaltrials.gov

Share:
Add to list

Context Interventions: Social Modeling and Initial Treatment Experience

Study ID: NCT04646460
Start Date: 2025-12-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Observed Success

Observed Failure

Experienced Success

Experienced Failure

Sponsor

Trustees of Dartmouth College

Source: clinicaltrials.gov

Share:
Add to list

ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing

Study ID: NCT03767231
Start Date: 2025-11
End Date: 2027-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Xpert HCV Veral Load Finger-Stick Point-of-Care Test (CSPHIDE)

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Methamphetamine Isomer Pharmacology in Humans

Study ID: NCT06746831
Start Date: 2025-08
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

17

Intervention / Treatment

S-(+)-methamphetamine

R-(-)-methamphetamine

1:1 racemic mixture of two isomers

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor

Study ID: NCT06572631
Start Date: 2025-06-07
End Date: 2026-12-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

31

Intervention / Treatment

Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Cyclophosphamide

Decitabine

Echocardiography

Fludarabine

Leukapheresis

Magnetic Resonance Imaging

Positron Emission Tomography

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Effects of Whole Body Vibration Therapy on Cognitive Function, Balance, and Quality of Life in Older Adults With Mild Cognitive Impairment

Study ID: NCT06927882
Start Date: 2025-06-01
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

180

Intervention / Treatment

WBV Therapy Group

Placebo Group:

Control

Sponsor

Jouf University

Source: clinicaltrials.gov

Share:
Add to list

A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

Study ID: NCT06550882
Start Date: 2025-05-30
End Date: 2026-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

9

Intervention / Treatment

Loving

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Study ID: NCT06243731
Start Date: 2025-05-30
End Date: 2027-01-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

No Intervention

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy

Study ID: NCT06377982
Start Date: 2025-09
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

hUCB

Sponsor

StemCyte Taiwan Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list